Abstract: The study of the murine macrophage mannose receptor (MR) has been hampered by the lack of specific reagents. We have generated and characterized novel anti-MR monoclonal antibodies and used them to analyze MR expression in primary mouse macrophages (MØ). In BioGel-and thioglycollate-elicited MØ, interleukin (IL)-4 upregulated total cell-associated MR (cMR), correlating with enhanced surface expression. We investigated the influence of IL-10, a well-characterized deactivator of MØ function, on MR levels and observed that it had a similar effect to IL-4. In both cases, enhanced cMR levels translated into increased production of the soluble form of the receptor (sMR). We have demonstrated the presence of sMR in cultures of stable non-MØ transductants expressing full-length MR, indicating that the proteolytic activity responsible for cMR cleavage is not MØ-restricted. These data support a role for the MR in T helper cell type 2 cytokine-driven, immune responses and suggest a non-MØ contribution to sMR production in vivo. J. Leukoc. Biol. 73: 604 -613; 2003.
INTRODUCTION
The mannose receptor (MR) recognizes sugar moieties present on endogenous as well as foreign molecules. It was first described by its ability to mediate clearance of lysosomal hydrolases that share the presence of branched sugars with exposed mannose residues [1] . A role for the MR in this homeostatic process has been confirmed through the generation of MRdeficient mice [2] . These animals exhibited increased levels of multiple lysosomal enzymes under steady-state and inflammatory conditions. Therefore, this endocytic receptor seems to provide a clearance system for molecules that are up-regulated during inflammation, including ␤-glucuronidase, tissue plasminogen activator, and neutrophil-derived myeloperoxidase [1] . This binding is mediated by some of the eight C-type lectin domains (CRD) arranged in tandem, which are present in the extracellular domain of the MR [3] . Abundant MR-CRD-binding activity has been found in salivary glands, exocrine pancreas, and thyroid [4] . Further analysis led to the identification of the prohormone thyroglobulin as a novel MR ligand [4] . These results suggested a wider role for the MR in clearance of self-molecules. Because of its ability to interact through its CRD with molecular structures associated with multiple microbes, such as Candida albicans [5] , Pneumocystis carinii, [6, 7] , Mycobacterium tuberculosis [8, 9] , Klebsiella pneumoniae, and Streptococcus pneumoniae [10] , the MR is also considered a pattern-recognition receptor [11] .
A second lectin activity is mediated through the MR cysteine-rich (CR) domain. This extracellular domain recognizes sulfated N-acetyl-glucosamine or galactose residues present on glycoprotein hormones synthesized by the anterior pituitary [12] [13] [14] , chondroitin sulfate, and sulfated Lewis x [15] . Sulfated glycoforms of sialoadhesin and CD45 expressed by specialized myeloid cells in secondary lymphoid organs [16] have also been described as CR domain ligands (CRL) [17] . No microbeassociated sugars have been found to interact with this region of the receptor [10] .
The in situ distribution of the MR in the murine system has been analyzed using a rabbit polyclonal antiserum, which required the use of protease treatment [18] or prewetting of tissues [19] . Under these conditions, this reagent detected MR in tissue macrophages (MØ), sinusoidal and lymphatic endothelia, perivascular microglia, and mesangial cells [19] . Although no MR was observed on dendritic cells (DC) in naïve mice [19] , limited expression on recruited or activated DC has been detected in inflamed human skin [20] and tonsils [21] , indicating that the presence of MR in these antigen-presenting cells can occur under some circumstances in vivo. CRL ϩ cells do not themselves express the MR [19] . We hypothesized that these cells could interact with cell-associated MR (cMR) on MR ϩ cells and/or with a soluble form of the MR (sMR) [22] present in circulation [23] , whose origin is ill-defined.
MR expression by cultured murine MØ is well-documented. The T helper cell type 1 (Th1)-Th2 paradigm correlated with down-and up-modulation, respectively, of this receptor. Interferon-␥ reduced MR synthesis [24] , and interleukin (IL)-4 and IL-13, inducers of an alternative activation state in MØ [25] , have opposite effects [25, 26] . As a result of the limited availability of rabbit anti-MR polyclonal antiserum, these studies have been performed using biochemical approaches that could not provide information of the cellular heterogeneity in cultures or the subcellular distribution of the receptor in a quantitative manner.
Functional sMR has been detected in conditioned media from BioGel-elicited MØ [23] . Pulse-chase experiments demonstrated that this form of the receptor is released through proteolytic cleavage of the cMR by a metalloprotease [23] . Human monocyte-derived DC also produce sMR [27] .
To date, no information is available regarding MR levels in murine cells in the presence of exogenous IL-10, a cytokine produced by, among others, Th2 cells, subsets of regulatory T cells [28] , and stimulated MØ [29] . IL-10 induces a deactivated phenotype on MØ characterized by inhibition of proinflammatory cytokines [30, 31] . Analysis of MR protein expression under these conditions will expand our understanding of the physiological role of MØ found during repair processes and parasitic infections [32] or that could originate in the periphery through the action of regulatory T cells [28] .
In this report, we describe the generation and characterization of anti-mouse MR monoclonal antibodies (mAb) that could be used as MR-specific, detection reagents and as surrogate ligands to modulate MR activity. These unique reagents were used to assess MR regulation by IL-4 and IL-10 in two distinct populations of elicited, primary MØ, using a combination of flow cytometry and Western blotting. The effect of a metalloprotease inhibitor on MR processing and surface expression under these conditions has also been analyzed. Furthermore, we showed that sMR production is not restricted to cells of the MØ lineage, as stable cell lines expressing full-length MR also shed sMR. The implications of these findings for MR biology will be discussed.
MATERIALS AND METHODS

Reagents
Murine IL-4 and IL-10 were obtained from R&D Systems (Minneapolis, MN). Fluorescein isothiocyanate (FITC)-labeled mannose bovine serum albumin (BSA) and FITC-labeled galactose BSA were from Sigma (Poole, Dorset, UK) or EY Laboratories (San Mateo, CA). Mannan was from Sigma. Metalloprotease inhibitor BB2116 was a kind gift of Dr. Andrew Gearing of British Biotech (Oxford, UK). DiI(1,1Ј-Dioctadecyl-1-3,3,3Ј,3Ј-tetramethylindocarbocyanine perchlorate-labeled)-acetylated, low-density lipoprotein (AcLDL) was from Intracell (Rockville, MD).
Animals
BALB/c and C57BL/6J mice were kept under specific, pathogen-free conditions at the Sir William Dunn School of Pathology (Oxford, UK) and were used at 10 -12 weeks of age. All animals were handled in accordance with institutional guidelines.
Production of Fc chimaeric proteins
The chimaeric proteins CR-Fc [16] , CR-FNII-Fc [16] , CRD4-7-Fc [4] , and CD33-Fc (a generous gift from Paul R. Crocker, University of Dundee) were generated as described [4, 16] .
Generation of stable transductants
NIH3T3 cells were maintained in Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA) containing 10% fetal calf serum (FCS), 50 units/ml penicillin, and 50 g/ml streptomycin. Chinese hamster ovary (CHO) cells were maintained in F12 medium (Invitrogen) containing 10% FCS, 50 units/ml penicillin, and 50 g/ml streptomycin. Full-length MR was generated as follows: a HindIII fragment encoding the amino terminal end of MR, derived from the pIG-derived plasmid encoding the fusion protein CR-Fc [16] , was subcloned into the HindIII site of the pSH plasmid to introduce a SalI site at the 5Ј end. A SalI-Eco47III fragment was cloned between the SalI-Eco47III sites of the pUC18-derived plasmid containing MR cDNA starting at nucleotide 175 of the full-length clone (kindly provided by Dr. R. Alan B. Ezekowitz). To obtain stable cell lines, the cDNA clone was subcloned into the retroviral vector pFB(neo); (Stratagene, San Diego, CA) and was transfected into Phoenix ecotropic packaging cells using Fugene transfection reagent (Roche Molecular Biochemicals, Indianapolis, IN) following the manufacturer's instructions. After 48 h, retroviral supernatants were harvested and used to transduce NIH3T3 cells in the presence of 5 g/ml Polybrene (Sigma). CHO cells were transduced after treatment with tunicamycin as described [33] . Stable transductants were selected using 0.6 mg/ml geneticin (Sigma). NIH3T3-derived cells expressing MR were clonally selected by Western blot analysis using a rabbit polyclonal anti-mouse MR antiserum (kindly provided by Dr. Philip Stahl, Washington University Medical School, St. Louis, MO). CHO-derived cells were enriched by fluorescein-activated cell sorting (FACS), based on their ability to endocytose FITC-labeled, mannosylated BSA. NIH3T3-derived dectin-1 transductants are described elsewhere [34] .
Endocytosis assays
Using stable transductants
Cells plated on tissue culture-treated plastic were incubated with FITC-labeled mannose BSA, galactose BSA (5 g/ml), or Alexa 488-labeled rat mAb (5 g/ml) and were incubated at 37°C for 60 -120 min. After incubation, cells were washed with phosphate-buffered saline (PBS), harvested using trypsin-EDTA, and fixed in 2% formaldehyde in PBS. Uptake was quantified on a FACScalibur flow cytometer, using CellQuest software.
Using primary MØ
Thioglycollate-elicited, peritoneal MØ were cultured overnight in poly-Dlysine-treated tissue-culture plastic (Becton Dickinson Labware, Bedford, MA) Fig. 1 . Presence of MR induces specific uptake of mannose BSA by NIH3T3 and CHO cells. Wild-type (wt) and MR-expressing NIH3T3 and CHO cells were incubated with FITC-labeled mannose BSA (Man-BSA) or galactose BSA (Gal-BSA; 5 g/ml) for 90 min at 37°C, and uptake was quantified by flow cytometry as described in Materials and Methods.
containing 100 g/ml purified rat mAb cross-linked to the plastic as described [35] . After washing cells with Opti-MEM (Invitrogen), FITC-labeled galactose BSA or mannose BSA (5 g/ml) in Opti-MEM was added in the presence or absence of DiI-AcLDL (5 g/ml). After 30 min, plates were transferred to 4°C and washed with ice-cold PBS. MØ were suspended in PBS containing 10 mM EDTA by scraping, fixed using 2% formaldehyde, and analyzed as above.
Generation of anti-MR mAb
Fischer rats were immunized and boosted with 50 g CRD4-7-Fc in complete Freund's adjuvant or incomplete Freund's adjuvant, respectively. Four days before fusion, animals were boosted with 30 g CRD4-7-Fc in PBS. Spleens were collected, and splenocytes were fused to the Y3 myeloma cell line [36] . Selection of anti-MR Ab-producing hybridomas was performed by immunohistochemistry on mouse tissues as described below and confirmed by Western blot analysis of 3T3-MR, MØ cell lysates, and Fc-chimaeric proteins.
Antibody purification and labeling
Rat antibodies were purified from hybridoma supernatants using GammaBind Plus sepharose (Amersham Pharmacia Biotech, Uppsala, Sweden). Antibodies were labeled using an Alexa 488-labeling kit from Molecular Probes (Eugene, OR) and were biotinylated using Sulfo-NHS-biotin (Pierce, Rockford, IL), according to the manufacturers' instructions.
Immunohistochemistry
Fresh mouse tissues were embedded in Tissue-Tek OCT compound (Bayer Diagnostics) and were frozen on dry ice-cooled isopentane. Sections (5 m) were cut, air dried, and frozen. Sections were thawed at room temperature, fixed in ethanol or 2% paraformaldehyde in Hepes-buffered saline, permeabilized in 0.1% Triton X-100 in PBS, quenched using glucose oxidase or 3% H 2 O 2 , and blocked in 5% normal rabbit serum in PBS. Primary rat antibodies diluted in blocking buffer were added and incubated for 1 h at room temperature. Binding was detected using biotinylated rabbit anti-rat immunoglobluin (Ig; Vector, Peterborough, UK) and the HRP-ABC detection system (Vector). To test for MR expression in stable transfectants, cells were plated on coverslips and after overnight culture, were fixed using 2% paraformaldehyde in Hepes-buffered saline. MR detection was performed as before but using normal goat serum for blocking and horseradish peroxidase (HRP)-conjugated goat anti-rat Ig (Chemicon, Harrow, UK) for detection.
Fig. 2.
Anti-MR mAb specifically recognize MR transductants. (A) Flow cytometric analysis of CHO-MR and 3T3-MR using anti-MR mAb. Cells were harvested using trypsin-EDTA and fixed using 2% paraformaldehyde. To perform intracellular staining, fixed cells were permeabilized using 0.5% saponin, which was maintained throughout the procedure. Cells were labeled with an isotype control (IgG 2a) mAb, MR6F3, MR6C3, or MR5D3 at 10 g/ml. Binding was detected using FITC-labeled donkey-anti-rat IgG. No staining of nontransduced cells was observed (data not shown). (B) The epitope recognized by MR5D3 is within the CRD4-7 fragment of MR. Cell lysates from wt and 3T3-MR (20 g/line), 3T3-MR supernatant (20 l from 10x concentrated), and 30 ng CRD4-7-Fc, CR-FNII-Fc, CR-Fc, and CD33-Fc were electrophoresed under nonreducing conditions and transferred to nitrocellulose. MR5D3 binding was assessed using neat hybridoma supernatant and HRP-conjugated goat-anti-rat IgG. Molecular weight markers are shown. (C) MR5D3 binds specifically to 3T3-MR cells by immunocytochemistry. wt (3T3) and MR-expressing cells (3T3-MR) plated on coverslips were stained with purified MR5D3 (10 g/ml) and HRP-conjugated goat-anti-rat Ig as described in Materials and Methods.
Macrophage cultures
BioGel-and thioglycollate-elicited peritoneal cells were collected by lavage 4 days after intraperitoneal injection of each stimulus. MØ were selected by adherence for 2 h in Opti-MEM and were cultured in RPMI medium containing 10% FCS, 50 units/ml penicillin, and 50 g/ml streptomycin.
Detection of MR by Western blot
After removing the media, cells were washed in PBS and lysed in ice-cold lysis buffer (2% Triton X-100, 10 mM Tris-HCl, pH 8, 150 mM NaCl, 2 mM NaN 3 , 2 mM EDTA) containing protease inhibitors (Roche Molecular Biochemicals) for 45 min at 4°C. Lysates were harvested and centrifuged at 2000 rpm in a tabletop centrifuge to eliminate nuclei and were stored at -20°C. Protein concentration was determined using the bicinchoninic acid assay (Pierce). Cell lysates and supernatants were electrophoresed in a 6% sodium dodecyl sulfatepolyacrylamide gel under nonreducing conditions and were transferred to nitrocellulose using standard procedures. MR was visualized using a combination of anti-MR mAb and HRP-conjugated anti-rat IgG (Chemicon) or rabbit polyclonal antiserum and HRP-conjugated anti-rabbit IgG (Jackson Laboratories, Bar Harbor, ME). Binding was detected using an enhanced chemiluminescence reagent (Amersham Pharmacia Biotech, Bucks, UK).
Surface biotinylation
Cells plated in 9 cm 2 dishes were washed extensively in ice-cold PBS containing 10 mM CaCl 2 and 10 mM MgCl 2 (PBS/Ca 2ϩ /Mg 2ϩ ). Biotin solution (Sulfo-NHS-biotin, 0.5 mg/ml in PBS/Ca 2ϩ /Mg 2ϩ , Pierce) was then added (750 l/dish) and left for 30 min at 4°C. To stop the reaction, cells were incubated at 4°C with RPMI medium and washed with ice-cold PBS/Ca 2ϩ /Mg 2ϩ . Cell lysates were prepared as before but with further centrifugation at 100,000 g for 30 min. Total MR was immunoprecipitated using MR5D3 (10 g/ml) and Gammabind Plus sepharose. Detection of total MR was performed by Western blot analysis, using rabbit polyclonal antiserum against murine MR. Biotinylated protein was detected using streptavidin-HRP (Sigma).
FACS analysis
As there were no differences regarding MR expression between cells plated on bacteriologic or tissue culture-treated plastic (data not shown), the first substrate, which facilitates cell recovery with minimal cell damage, was adopted for flow cytometry. MØ, plated on bacteriologic plastic, were harvested using 5
mAb, at 10 g/ml) for 45 min at 4°C, and incubated with primary rat Ab (10 g/ml in blocking buffer) for 1 h. After this incubation, cells were washed three times in washing buffer and fixed in 2% formalin in PBS. If the primary Ab was not labeled, 2.4G2 treatment was omitted, and FITC-conjugated donkey anti-rat IgG (Jackson Laboratories) diluted 1:100 in blocking buffer was added after the washes. After 45 min, samples were processed as before. If biotinylated Ab were used, detection was performed using streptavidin-allophycocyanin (APC; PharMingen, San Diego, CA). Control, biotinylated IgG2a was from PharMingen. Phycoerythrin (PE)-labeled F4/80 was from Serotec (Oxford, UK).
For total MR labeling, cells were fixed in 2% paraformaldehyde in PBS for 30 min at 4°C, and all incubations were performed in the presence of 0.5% saponin (Sigma).
RESULTS
Generation of stable transductants expressing functional MR
Two stable cell lines, 3T3-MR and CHO-MR, expressing fulllength, functional, murine MR, were generated by transduction of NIH3T3 and CHO cells, respectively. Both transduced cell lines selectively endocytosed FITC-labeled, mannosylated BSA ( Fig. 1) and biotinylated D-mannose coupled to a soluble polyacrylamide support (data not shown). Uptake was inhibited by mannan (0.5 mg/ml). This activity correlated with the presence in cell lysates from 3T3-MR of a 175-kDa molecule that cross-reacted with a rabbit polyclonal serum raised against mouse MR (data not shown).
Generation of antimurine MR mAb
Hybridomas were screened by immunohistochemistry, and antibodies that labeled tissues following a MR-staining pattern similar to that described by Linehan et al. [19] were selected, cloned, and expanded. Three mAb (MR6F3, MR6C3, and MR5D3), all IgG2a, were purified and tested by flow cytometry for binding to MR-transduced and nontransduced (wt) cells. None showed binding to the wt cells (data not shown) but specifically labeled MR-expressing cells (Fig. 2A) . An apparent binding hierarchy that correlated with Western blot analysis (data not shown) was observed, indicating that MR5D3 probably recognized murine MR with highest affinity. As shown in Figure 2B , the CRD4-7 region of the receptor contained the MR5D3 epitope, as assessed by its recognition of cell-associated and soluble MR in cell lysates and supernatants from 3T3-MR and of the recombinant protein CRD4-7-Fc. As expected, based on the selection procedure, these reagents labeled transduced cells by immunocytochemistry ( Fig. 2C; and data not shown) .
J774E, a murine MØ cell line selected for high expression of MR [37] , was chosen to assess the specificity of these reagents in MØ-like cells. As shown in Figure 3A , MR6C3 and MR5D3 labeled J774E cells but failed to recognize J774 cells, which in our hands, do not express MR (data not shown). These results indicate that there was neither cross-reactivity with other MØ molecules nor high background as a result of Fc receptors. The expression pattern of the MR in mouse tissues was reassessed using purified MR5D3. The pattern observed with the polyclonal reagent [19] was confirmed, but in this Western blot analysis of cMR and sMR expression in cell lysates (Cells) and supernatants (Sups) from BioGel-elicited, peritoneal MØ. Cells cultured as described in Materials and Methods were left untreated (Unt) or treated with IL-4 (10 ng/ml) or IL-10 (100 U/ml). After 2 days, cell lysates and supernatants were harvested and analyzed for MR expression using purified MR5D3 (2 g/ml) and HRP-conjugated goat anti-rat Ig. (B) FACS analysis of total cMR expression in BioGel (Bg) and thioglycollate (Thio)-elicited MØ at days 1-3 of culture in the absence of cytokines or in the presence of IL-4 (10 ng/ml) or IL-10 (100 U/ml). Cells, plated on bacteriologic plastic, were harvested using 5 mM EDTA in PBS, fixed with 2% paraformaldehyde, and permeabilized. Alexa 488-conjugated isotype-control IgG2a (dotted line), MR5D3, and MR6C3 were used in these assays. Similar binding of the isotype-control mAb in all conditions was observed (data not shown). Only MR5D3 labeling of MR is shown, but similar labeling results were obtained for MR6C3. Although a slight time-dependent cMR up-regulation was detected in untreated cultures (thick line), an enhanced cMR expression occurred in the presence of IL-4 (dotted and dashed lines) and IL-10 (thin line), and most cells expressed high levels of the receptor by day 3.
case, there was no requirement for prewetting the tissues before fixation or protease treatment for detection. MR expression detected by mAb MR5D3 in lung (alveolar MØ), spleen (red pulp), and liver (Kupffer cells and liver endothelium) is shown in Figure 3B .
Use of anti-mouse MR mAb as tools to analyze MR function
To determine if anti-MR mAb could be used as MR-specific endocytic tracers, wt NIH3T3 and NIH3T3-derived, stable transductants expressing the MR or the ␤-glucan receptor (dectin-1) were incubated with several Alexa 488-labeled mAb. As shown in Figure 4A , only cells expressing MR showed specific uptake of anti-MR mAb regardless of the relatively elevated uptake of the IgG2a control mAb observed for all cell types. Unexpectedly, internalization of MR6F3 and MR6C3 was more efficient than that of MR5D3. These differences could not be explained by differences in the conjugation levels of the mAb or by enhanced binding properties upon labeling, as they all labeled unfixed, freshly isolated thioglycollate-elicited MØ in a similar manner (data not shown).
To determine if anti-MR mAb could be used to modulate MR activity in primary MØ, thioglycollate-elicited MØ were plated on anti-MR or control mAb, and their ability to take up FITC-labeled mannose BSA was assessed. As shown in Figure  4B , a substantial decrease in the amount of internalized mannose BSA was observed in MØ plated on the MR-specific mAb MR5D3 and MR6F3. Under these conditions, uptake of DiIAcLDL, an endocytic tracer specific for scavenger receptors, remained largely unaffected.
MR in primary MØ cultures is up-regulated by IL-4 and IL-10
MR expression on BioGel-elicited, peritoneal MØ was analyzed by Western blot using MR5D3 (Fig. 5A) . At the concentration tested, IL-10 enhanced MR expression in cell lysates and supernatants. This increase was comparable with that observed with IL-4. These conclusions were further supported by FACS analysis of thioglycollate-and BioGel-elicited MØ. Detailed analysis of total cMR expression in permeabilized cells at different times is shown in Figure 5B . A steady increase in the number of high MR expressing cells up to day 3 can be observed.
Surface MR expression is not affected by proteolytic cleavage
Although most MR is located intracellularly in early endosomal compartments [1] , surface staining can be achieved in nonfixed cells by FACS analysis using biotinylated antibodies and APCconjugated streptavidin. As shown in Figure 6 , increased, total cMR expression translated into enhanced surface labeling, indicating that surface expression was not specifically influenced by the cytokines tested.
Shedding has been shown to be an effective mechanism to regulate surface expression [38] . To determine if the metalloprotease-mediated cleavage of cMR regulated the cell-surface expression of MR, cells cultured overnight with the metalloprotease inhibitor BB2116 were tested for total and surface cMR levels. As shown in Figure 7A , no major differences in MR surface levels were observed in the presence of this compound, indicating that cleavage per se did not control the amount of cMR at the cell surface. These results were confirmed by surface biotinylation and immunoprecipitation studies (Fig. 7B) . Although BB2116 dramatically reduced the amount of sMR in MØ-conditioned media in the absence or presence of IL-4 (Fig. 7B, upper) , it did not substantially increase MR surface expression (Fig. 7B, lower) . Under these conditions, IL-4 treatment increased the amount of biotinylated receptor, which is consistent with the FACS analysis data shown in Figure 5 .
Production of sMR by MR stable transductants
Cell lysates and supernatants from CHO and 3T3 (wt and MR transductants) cells were analyzed for the presence of MR (Fig.  8) . A cleavage product that comigrated with the form produced by BioGel-elicited MØ was detected in the conditioned media from the transductants.
DISCUSSION
The MR is a well-characterized, endocytic receptor involved in homeostasis and immunity. Its recognition of self-derived [1, 2, 4, 12] and foreign molecules [11] together with its regulated expression by MØ [24 -26] and the presence of MR-CR domain ligands in secondary lymphoid organs [16, 39, 40] make it a suitable model to analyze the interplay between the immunological and physiological functions performed by MØ. In the murine system, the study of MR biology has been limited by the lack of specific reagents. We are first to report the generation of antimurine MR mAb, MR5D3, MR6F3, and MR6C3. These reagents detect recombinant and native receptors by Western blotting, flow cytometry, immunoprecipitation, and immunohistochemistry. Anti-MR mAb would be valuable for the analysis of MR regulation in situ and in vitro under normal and pathological conditions and the characterization of MR ϩ cells ex vivo. Additionally, these reagents could be used as highly specific MR surrogate ligands, an approach that has been successfully used in other systems [21, 41, 42] and in the identification of signaling pathways that are triggered upon MR ligation. Results from previous attempts have been inconclusive as a result of the complex nature of the ligand(s) used [43] and the existence of additional mannose-binding lectins [44, 45] . No blocking activity was observed for MR6F3, MR6C3, or MR5D6 in in vitro binding assays in which the interaction of sMR with immobilized MR-specific ligands was analyzed [10] . . On the following day, cell lysates (Cells) and supernatants (Sup) were harvested and assessed for the presence of MR. Although cMR levels in cell lysates were not affected by the presence of BB2116, there was a major reduction of the levels of sMR in supernatants in the presence of this compound. (Lower) Thioglycollate-elicited MØ cultured for 3 days in the absence (-) or presence (ϩ) of IL-4 and treated overnight (ϩ) with BB2116 (50 g/ml) were washed, and surface proteins were biotinylated as described in Materials and Methods. Total cell lysates were prepared, and MR was immunoprecipitated using MR5D3 (10 g/ml) and GammaBind Plus sepharose. Immunoprecipitated material was electrophoresed and transferred to nitrocellulose. Detection of total cMR was achieved using a rabbit polyclonal antiserum against MR (anti-MR) and of biotinylated protein, using HRP-conjugated Extravidin. Approximately 50% inhibition of mannose-BSA uptake by MR-3T3 was observed when high concentrations (40 g/ml) of MR6F3 were used (data not shown). Nevertheless, these reagents have proved to be useful in down-modulating MR activity in primary MØ cultures by sequestrating the receptor from the cell surface.
We used the anti-MR mAb to assess MR regulation in cultured MØ by two Th2 cytokines, IL-4 and IL-10. Our results confirmed the reported up-regulation of cMR and sMR levels in response to IL-4 in BioGel-elicited MØ [25] and provided additional data showing enhanced surface cMR expression under these conditions and heterogeneity in primary MØ cultures in regard to MR expression. Furthermore, we demonstrated that these effects are not restricted to this particular MØ population, as peritoneal MØ elicited by the sterile stimulus thioglycollate broth responded in a similar manner. sMR production, enhanced by IL-4 treatment, was also detected in conditioned media from thioglycollate-elicited MØ.
We have detected increased MR expression in response to IL-10 in the two murine peritoneal MØ populations tested. These results increase the number of overlapping effects on MØ between IL-4 and IL-10. Both cytokines have been shown to increase arginase activity in murine MØ [46] . Although enhanced MR expression normally correlates with enhanced endocytic capacity, further analysis of MR function in IL-10-treated MØ is required to clarify the role of this receptor on these cells. In agreement with our results, IL-10 has been reported to increase MR expression in human monocyte-derived DC [47] , but reduced endocytic activity has been described in human monocyte-derived MØ treated with IL-10 [48] .
Cell-surface expression of cMR did not appear to be regulated by metalloprotease activity, as levels of cMR at the cell surface remained unchanged in the presence of BB2116, a major inhibitor of cMR cleavage. In contrast, the production of sMR in the presence or absence of IL-4 was almost totally abolished in the presence of BB2116. Therefore, sMR production doesn't seem to represent a byproduct of MR synthesis involved in the control of cMR surface expression. The detection of ligands for the MR-CR domain in secondary organs, cells that surround B cell follicles in naïve animals, which can be found within B cell areas upon stimulation (CRL ϩ cells) [16, 39, 40] , inspired the "sMR-mediated antigen-delivery hypothesis." According to this hypothesis, sMR could act as a bifunctional molecule and transport CRD-bound ligands to CRL ϩ cells [22] . Purified sMR from 3T3-MR cells fulfilled the functional requirements for such a role, as it bound SO 4 -3-galactose (a CR domain ligand) and bacterial capsular polysaccharides (CRD ligands) simultaneously [10] . The results presented in this work strengthen the case for a specific function for the sMR in vivo.
Stable transductants expressing full-length MR offered a suitable system to analyze the requirement for a MØ-restricted protease for the proteolytic cleavage of cMR to produce sMR. As sMR could be readily detected in the conditioned media of MR transductants, we conclude that the ability to produce sMR through cleavage of cMR is widely distributed. In vivo [23] , sMR could be derived from lymphatic and hepatic endothelia, among others [19] , in addition to MØ.
In summary, we describe the generation of highly specific mAb against murine MR. These mAb have proved useful in a wide range of techniques, such as Western blotting, immunohistochemistry, flow cytometry, immunoprecipitation, and affinity chromatography, and hence, are powerful tools for the analysis of MR regulation. We demonstrated that up-regulation of MR by IL-4 is not restricted to BioGel-elicited MØ and that IL-10 also has a positive effect on the expression of this molecule. Finally, our results indicate that sMR production does not affect surface cMR levels and that circulating sMR can derive from all MR ϩ cells.
